Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex

Go back to Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex
PARTNERRE LTD. (NASDAQ: PRE) Delayed: 23.84 -0.35 (1.45%)
Previous Close $24.19    52 Week High $141.25 
Open $24.41    52 Week Low $111.52 
Day High $24.75    P/E 2.25 
Day Low $23.81    EPS $10.58 
Volume 58,281       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 23.84 -0.35 (1.45%)
Previous Close $24.19    52 Week High $141.25 
Open $24.41    52 Week Low $111.52 
Day High $24.75    P/E 2.25 
Day Low $23.81    EPS $10.58 
Volume 58,281       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 23.84 -0.35 (1.45%)
Previous Close $24.19    52 Week High $141.25 
Open $24.41    52 Week Low $111.52 
Day High $24.75    P/E 2.25 
Day Low $23.81    EPS $10.58 
Volume 58,281